We had the pleasure of speaking with David Saad, CBRE Executive Vice President who runs their life sciences group here in Denver. We’re excited to have him walk us through CBRE’s annual 2025 Life Sciences Outlook and provide insight into how it pertains to the Colorado market and what the future of life sciences real estate looks like in the Denver-Boulder-Aurora region, and specifically on the Fitzsimons Innovation Community campus.
Melissa Krebs, Ph.D., CEO and Founder of Community member GelSana, has been inducted into the American Institute for Medical and Biological Engineering (AIMBE) College of Fellows. This prestigious honor recognizes her pioneering advancements in cell-interactive biomaterials and their clinical translation, particularly in regenerative medicine and drug delivery technologies. Her innovative work is making significant strides…
BNBuilders announced the completion of a new 5,500-square-foot office and lab space for RefinedScience at the Fitzsimons Innovation Community Campus. This modern, functional environment is designed to support scientific innovation and enhance collaboration.
This Phase 3b trial suggests that semaglutide 1.0 mg (Ozempic) could become the first therapy in nearly 20 years to gain regulatory approval for improving functional outcomes in patients with peripheral artery disease (PAD) and type 2 diabetes (T2D). sciences real estate markets in our region, and why Fitzsimons is uniquely positioned to welcome new…
Change Please Coffee at Fitzsimons Innovation Community in Aurora is a coffee shop that is doing good in the community by helping people get back on their feet.
Inside Precision Medicine recently highlighted Community member RheumaGen’s mission to develop one-time, curative CGT treatments for autoimmune diseases. Read more about their innovative approach and hear from Co-founder and CEO, Richard Freed.
At Fitzsimons Innovation Community, women in STEM isn’t just a buzz phrase. Many of the innovative companies on our campus are led, founded, and staffed by women scientists, physicians, and inventors doing remarkable work. In celebration of Women’s History Month and International Women’s Day, we spoke with some of the esteemed women leaders and innovators from three organizations that call Fitzsimons Innovation Community home.
Challenges in the Denver-Boulder life sciences real estate market have leveled off with a spike in leasing activity and venture capital funding to local companies at the end of 2024.
Talking leadership and the future with Fitzsimons Innovation Community’s New President and CEO. Kelly Brough likes to get stuff done. Her fast-moving, no-nonsense leadership style, commitment to meeting goals, and ability to bring people together are the qualities that drew the Fitzsimons Innovation Community Board of Directors to bring her on as our new President and CEO. This month, we were excited to sit down with her and discuss her style, her agenda, and what she’s ready to get done for Fitzsimons Innovation Community. It’s a Q and A that left us inspired and fired up for what she has in store.
The University of Colorado Anschutz Medical Campus was once again recognized as an R1 institution by the Carnegie Classification of Institutions of Higher Education, a designation shared with the University of Colorado Denver that places it among the nation’s most elite research institutions. This recognition underscores CU Anschutz’s status as a leader in transformative research,…